Abstract
Background: The COVID-19 pandemic affected by the new Coronavirus SARS-CoV-2 continues to spread globally, increasing the burden on countries’ Health Care systems. Therefore, generating a platform to help diagnose and monitor COVID-19 patients remotely is considered an essential issue today. In particular, the SpO2 index plays a vital role in COVID-19 disease and is selected to monitor patients at health facilities and homes. This study aimed to evaluate the initial effectiveness of the remote SpO2 monitoring system in patients with mild - to - moderate COVID-19 diseases.
Methods: This cross - section study was conducted on mild - to - moderate COVID-19 patients treated at the COVID-19 Intensive Care Center operated by Hue Central Hospital in Ho Chi Minh City, Vietnam
Results: From August 2021 to October 2021, 32 COVID-19 patients were applied with SpO2 monitoring smartwatches. The mean age was 34.2 ± 12.0. Risk factors including obesity (25%), smoking (18.8%), hypertension (15.6%), and diabetes (12.5%). Most patients were admitted to the center due to shortness of breath (71.9%) and transferred from lower - level hospitals (62.5%). The main clinical symptoms are coughing, sneezing, runny nose (40.6%), followed by a decrease or loss of smell and taste (25%). 81.3% of patients had D-Dimer ≤ 500 ng/mL. 62.5% of patients had moderate COVID-19 grades. A total of 3,161 SpO2 measurements, including 8 alarms < 93%. The average SpO2 was 98.1 ± 0.2 %. All patients were discharged successfully.
Conclusion: A remote SpO2 monitoring system is considered to have preliminary effectiveness in monitoring mild - to - moderate COVID-19 patients.
References
Hu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.
WHO. Weekly epidemiological update on COVID-19 - 19 October 2021. 2021 [cited Oct 2021]; 62; Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---19-october-2021.
Cục Y Tế Dự phòng. Bản tin cập nhật COVID-19 tính đến 18h00 ngày 31/10/2021. 2021 [cited Oct 2021]; Available from: https://vncdc.gov.vn/ban-tin-cap-nhat-covid-19-tinh-den-18h00-ngay-31102021-nd16660.
Motta LP, Silva P, Borguezan BM, Amaral J, Milagres LG, Boia MN, et al. An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application. PLoS One. 2021;16:e0247635.
Pedone C, Chiurco D, Scarlata S, Incalzi RA. Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial. BMC Health Serv Res. 2013;13:82.
O'Carroll O, MacCann R, O'Reilly A, Dunican EM, Feeney ER, Ryan S, et al. Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia. Eur Respir J. 2020;56:420-2.
Shah S, Majmudar K, Stein A, Gupta N, Suppes S, Karamanis M, et al. Novel Use of Home Pulse Oximetry Monitoring in COVID-19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization. Acad Emerg Med. 2020;27:681-92.
Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị COVID-19 do chủng vi rút Corona mới (SARS-CoV-2). 2021: Hà Nội.
WHO. The Asia-Pacific perspective: redefining obesity and its treatment. 2000.
O'Driscoll BR, Howard LS, Earis J, Mak V. British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017;4:e000170.
TMA Innovation. Giải pháp hỗ trợ theo dõi sức khỏe F0 tại các bệnh viện dã chiến. 2021 Oct 2021; Available from: https://suckhoevang.vn/giai-phap-ho-tro-theo-doi-suc-khoe-f0-tai-cac-benh-vien-da-chien.
Silicon Labs. Si1182-GM Biometric HRM Sensors. 2021 Oct 2021; Available from: https://www.silabs.com/sensors/biometric/si118x/device.si1182-gm.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21:855.
Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350-9.
Kim GU, Kim RA, SH Lee, J Bae S, Jung J, et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020;26:948.e1-3.
Liao Y, Feng Y, Wang B, Wang H, Huang J, Wu Y, et al. Clinical characteristics and prognostic factors of COVID-19 patients progression to severe: a retrospective, observational study. Aging (Albany NY). 2020;12:18553-65.
Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8:49.
Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, Bajracharya T, et al. D-dimer as a biomarker for assessing of COVID-19 prognosis: D-dimer levels on admission and role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One. 2021;16:e0256744.
Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Med Devices (Auckl). 2014;7:231-9.
Hahnen C, Freeman CG, Haldar N, Hamati JN, Bard DM, Murali V, et al. Accuracy of Vital Signs Measurements by a Smartwatch and a Portable Health Device: Validation Study. JMIR Mhealth Uhealth. 2020;8:e16181.
Barros GM, Anjos MS, Mazullo Filho JBR. Smartwatch, oxygen saturation, and COVID-19: Trustworthy? ABCS Health Sciences. 2021;46:e021101.
Aoyagi T. Pulse oximetry: its invention, theory, and future. J Anesth. 2003;17:259-66.
Luks AM, Swenson ER. Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance. Ann Am Thorac Soc. 2020;17:1040-6.
Lee H, Ko H, Lee J. Reflectance pulse oximetry: Practical issues and limitations. ICT Express. 2016;2:195-8.
Kavasoglu AR, Polat K, Bozkurt MR. An innovative peak detection algorithm for photoplethysmography signals: an adaptive segmentation method. Turk J Elec Eng & Comp Sci. 2016;24:1782-96.
OxiTone Medical Inc. Model OxiTone® 1000M. 2021 [cited Oct 2021]; Available from: https://www.oxitone.com/oxitone-1000m.
Kirszenblat R, Edouard P. Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study. J Med Internet Res. 2021;23:e27503.
Alavi A, Bogu GK, Wang M, Rangan ES, Brooks AW, Wang Q, et al. Real-time Alerting System for COVID-19 Using Wearable Data. medRxiv. 2021.
Rahman A, Tabassum T, Araf Y, Al Nahid A, Ullah MA, Hosen MJ. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol Biol Rep. 2021;48:3863-9.
| Published | 01-01-2022 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 75 (2022) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.2022.75.4 | |
| Keywords | COVID-19, bão hòa oxy máu, đồng hồ thông minh, hệ thống theo dõi sức khỏe. COVID-19, blood oxygen saturation, smartwatch, health monitoring system. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Journal of Clinical Medicine Hue Central Hospital